Back
Fulcrum Therapeutics Stock Price Chart
AI Is Disrupting Marketing - Invest in the Shift
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.
Sell
13
FULC
Fulcrum Therapeutics
Last Price:
$3.13
Seasonality Move:
-17.07%
7 Day Trial
ALL ACCESS PASS
$
7
Your Data Made Them Billions-Now It's Your Turn to Profit
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FULC is experiencing slight buying pressure.
Fulcrum Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.11 | Buy |
| 20-day SMA: | 3.42 | Sell |
| 50-day SMA: | 3.89 | Sell |
| 200-day SMA: | 5.39 | Sell |
| 8-day EMA: | 3.13 | Sell |
| 20-day EMA: | 3.36 | Sell |
| 50-day EMA: | 3.68 | Sell |
| 200-day EMA: | 4.9 | Sell |
Fulcrum Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.24 | Sell |
| Relative Strength Index (14 RSI): | 39.64 | Sell |
| Chaikin Money Flow: | 345399 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.16 - 3.78) | Sell |
| Bollinger Bands (100): | (3.25 - 4.29) | Sell |
Fulcrum Therapeutics Technical Analysis
| Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | Mar | |||||||||
| 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Fulcrum Therapeutics Stock
Is Fulcrum Therapeutics Stock a Buy?
-
Fulcrum Therapeutics share price is 3.12 while FULC 8-day simple moving average is 3.11, which is a Buy signal.
-
The stock price of FULC is 3.12 while Fulcrum Therapeutics 20-day SMA is 3.42, which makes it a Sell.
-
Fulcrum Therapeutics 50-day simple moving average is 3.89 while FULC share price is 3.12, making it a Sell technically.
-
FULC stock price is 3.12 and Fulcrum Therapeutics 200-day simple moving average is 5.39, creating a Sell signal.
FULC Technical Analysis vs Fundamental Analysis
Sell
13
Fulcrum Therapeutics (FULC)
is a Sell
Is Fulcrum Therapeutics a Buy or a Sell?
-
Fulcrum Therapeutics stock is rated a SellThe current Fulcrum Therapeutics [FULC] share price is $3.12. The Score for FULC is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
Fulcrum Therapeutics Stock Info
Market Cap:
168.4M
Price in USD:
3.12
Share Volume:
734K
Fulcrum Therapeutics 52-Week Range
52-Week High:
11.48
52-Week Low:
2.78
Sell
13
Fulcrum Therapeutics (FULC)
is a Sell
Fulcrum Therapeutics Share Price Forecast
-
What is the Fulcrum Therapeutics stock price today?The Fulcrum Therapeutics stock price is 3.12 USD today.
-
Will FULC stock go up or go down?Fulcrum Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Fulcrum Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Fulcrum Therapeutics is overvalued.
Is Fulcrum Therapeutics Stock a Buy?
-
Fulcrum Therapeutics share price is 3.12 while FULC 8-day exponential moving average is 3.13, which is a Sell signal.
-
The stock price of FULC is 3.12 while Fulcrum Therapeutics 20-day EMA is 3.36, which makes it a Sell.
-
Fulcrum Therapeutics 50-day exponential moving average is 3.68 while FULC share price is 3.12, making it a Sell technically.
-
FULC stock price is 3.12 and Fulcrum Therapeutics 200-day simple moving average is 4.90, creating a Sell signal.
Fundamental Analysis of Fulcrum Therapeutics
Is Fulcrum Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.11 per share, and an increase next year of $0.06 per share.
Technical Analysis of Fulcrum Therapeutics
Should I short Fulcrum Therapeutics stock?
-
FULC Moving Average Covergence Divergence (MACD) indicator is -0.24, suggesting Fulcrum Therapeutics is a Sell
-
Fulcrum Therapeutics Relative Strength Index (RSI) is 39.64, which suggest Fulcrum Therapeutics is oversold
-
The Bollinger Bands (25) for Fulcrum Therapeutics is (3.16 - 3.78), which suggest Fulcrum Therapeutics is a Sell
-
The Bollinger Bands (100) for Fulcrum Therapeutics is (3.25 - 4.29), which suggest Fulcrum Therapeutics is a Sell
* Fulcrum Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.